{"id":54276,"date":"2023-02-27T18:03:02","date_gmt":"2023-02-27T17:03:02","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/fcw-selects-mitres-dr-jay-schnitzer-as-a-2023-federal-100-honoree\/"},"modified":"2023-02-27T18:03:02","modified_gmt":"2023-02-27T17:03:02","slug":"fcw-selects-mitres-dr-jay-schnitzer-as-a-2023-federal-100-honoree","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/fcw-selects-mitres-dr-jay-schnitzer-as-a-2023-federal-100-honoree\/","title":{"rendered":"FCW Selects MITRE\u2019s Dr. Jay Schnitzer as a 2023 Federal 100 Honoree"},"content":{"rendered":"
\n

BEDFORD, Mass.–(BUSINESS WIRE)–#Cancer<\/a>—FCW<\/a> named Jay Schnitzer<\/a>, MD, Ph.D., MITRE chief technology and medical officer, to the 2023 Federal 100<\/a> for his leadership in enabling better health outcomes for patients by unlocking the vast research and treatment insights of interoperable electronic health records (EHRs).\n<\/p>\n

<\/a><\/p>\n

\nSchnitzer guides MITRE\u2019s $100M independent research and development portfolio<\/a>, including the company\u2019s initiative to use patient data to help cure cancer. In 2019, Schnitzer and current Director of the National Cancer Institute, Dr. Monica Bertagnolli, engaged a consortium of nonprofits to launch mCODE\u2122<\/a> (minimal Common Oncology Data Elements), a common data standard and language for cancer care that can be incorporated into EHRs. mCODE enables access to anonymized data on the characteristics, treatments, and outcomes of cancer patients, which can then be analyzed to find new insights and improve cancer treatments.\n<\/p>\n

\n\u201cWe are extremely proud of Jay and celebrate FCW\u2019s recognition of his ongoing and determined pursuit to bring more targeted and effective treatments to patients by harnessing data insights at scale,\u201d said MITRE President & Chief Executive Officer Jason Providakes<\/a>, Ph.D. \u201cAnd while Jay has many accomplishments as a surgeon, chemical engineer, and leader, his true gift is that of a \u2018connector\u2019 forging teams across academia, industry, and government to tackle the biggest challenges in health \u2013 including cancer.\u201d\n<\/p>\n

\nThe maturation of mCODE, formalized in implementation guides for different therapies and approved by the Health Level Seven International (HL7)<\/a> standards body, led to the formation of CodeX\u2122<\/a>, a public-private partnership, to identify additional use cases in healthcare and drive adoption of the mCODE standard.\n<\/p>\n

\nIn 2022, mCODE expanded<\/a> its clinical trials pilot to more than 60 health organizations; CodeX grew to 43 members and the mCODE approach was adapted for other diseases and use in cardiology. MITRE\u2019s collaborative role in helping to \u201cfacilitate research participation; and establish a portable, shareable, standardized cancer health record\u201d was recently cited by the White House<\/a> in an update to the Biden Administration\u2019s own Cancer Moonshot.\n<\/p>\n

\nFCW will honor the Federal 100 award winners at a ceremony <\/a>in Washington, D.C., on April 20. For 34 years, the awards have celebrated government, industry, and academic leaders who are transforming government and its ability to deliver on critical missions.\n<\/p>\n

\nABOUT MITRE<\/b>\n<\/p>\n

\nMITRE\u2019s mission-driven teams are dedicated to solving problems for a safer world. Through public-private partnerships and federally funded R&D centers, MITRE works across government and in partnership with industry to tackle challenges to the safety, stability, and well-being of our nation. Learn more at mitre.org<\/a>.\n<\/p>\n

Contacts<\/b> <\/p>\n

\nMike Murphy, media@mitre.org<\/a>\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

BEDFORD, Mass.–(BUSINESS WIRE)–#Cancer—FCW named Jay Schnitzer, MD, Ph.D., MITRE chief technology and medical officer, to the 2023 Federal 100 for his leadership in enabling better health outcomes for patients by unlocking the vast research and treatment insights of interoperable electronic health records (EHRs). Schnitzer guides MITRE\u2019s $100M independent research and development portfolio, including the company\u2019s … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-54276","6":"format-standard","7":"category-industry"},"yoast_head":"\nFCW Selects MITRE\u2019s Dr. Jay Schnitzer as a 2023 Federal 100 Honoree - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/fcw-selects-mitres-dr-jay-schnitzer-as-a-2023-federal-100-honoree\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"FCW Selects MITRE\u2019s Dr. Jay Schnitzer as a 2023 Federal 100 Honoree - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"BEDFORD, Mass.–(BUSINESS WIRE)–#Cancer—FCW named Jay Schnitzer, MD, Ph.D., MITRE chief technology and medical officer, to the 2023 Federal 100 for his leadership in enabling better health outcomes for patients by unlocking the vast research and treatment insights of interoperable electronic health records (EHRs). Schnitzer guides MITRE\u2019s $100M independent research and development portfolio, including the company\u2019s ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/fcw-selects-mitres-dr-jay-schnitzer-as-a-2023-federal-100-honoree\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2023-02-27T17:03:02+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20230227005632\/en\/774866\/21\/https_commmitre.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/fcw-selects-mitres-dr-jay-schnitzer-as-a-2023-federal-100-honoree\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/fcw-selects-mitres-dr-jay-schnitzer-as-a-2023-federal-100-honoree\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"FCW Selects MITRE\u2019s Dr. Jay Schnitzer as a 2023 Federal 100 Honoree\",\"datePublished\":\"2023-02-27T17:03:02+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/fcw-selects-mitres-dr-jay-schnitzer-as-a-2023-federal-100-honoree\\\/\"},\"wordCount\":436,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/fcw-selects-mitres-dr-jay-schnitzer-as-a-2023-federal-100-honoree\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230227005632\\\/en\\\/774866\\\/21\\\/https_commmitre.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/fcw-selects-mitres-dr-jay-schnitzer-as-a-2023-federal-100-honoree\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/fcw-selects-mitres-dr-jay-schnitzer-as-a-2023-federal-100-honoree\\\/\",\"name\":\"FCW Selects MITRE\u2019s Dr. Jay Schnitzer as a 2023 Federal 100 Honoree - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/fcw-selects-mitres-dr-jay-schnitzer-as-a-2023-federal-100-honoree\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/fcw-selects-mitres-dr-jay-schnitzer-as-a-2023-federal-100-honoree\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230227005632\\\/en\\\/774866\\\/21\\\/https_commmitre.jpg\",\"datePublished\":\"2023-02-27T17:03:02+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/fcw-selects-mitres-dr-jay-schnitzer-as-a-2023-federal-100-honoree\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/fcw-selects-mitres-dr-jay-schnitzer-as-a-2023-federal-100-honoree\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/fcw-selects-mitres-dr-jay-schnitzer-as-a-2023-federal-100-honoree\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230227005632\\\/en\\\/774866\\\/21\\\/https_commmitre.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230227005632\\\/en\\\/774866\\\/21\\\/https_commmitre.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/fcw-selects-mitres-dr-jay-schnitzer-as-a-2023-federal-100-honoree\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"FCW Selects MITRE\u2019s Dr. Jay Schnitzer as a 2023 Federal 100 Honoree\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"FCW Selects MITRE\u2019s Dr. Jay Schnitzer as a 2023 Federal 100 Honoree - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/fcw-selects-mitres-dr-jay-schnitzer-as-a-2023-federal-100-honoree\/","og_locale":"en_US","og_type":"article","og_title":"FCW Selects MITRE\u2019s Dr. Jay Schnitzer as a 2023 Federal 100 Honoree - Pharma Trend","og_description":"BEDFORD, Mass.–(BUSINESS WIRE)–#Cancer—FCW named Jay Schnitzer, MD, Ph.D., MITRE chief technology and medical officer, to the 2023 Federal 100 for his leadership in enabling better health outcomes for patients by unlocking the vast research and treatment insights of interoperable electronic health records (EHRs). Schnitzer guides MITRE\u2019s $100M independent research and development portfolio, including the company\u2019s ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/fcw-selects-mitres-dr-jay-schnitzer-as-a-2023-federal-100-honoree\/","og_site_name":"Pharma Trend","article_published_time":"2023-02-27T17:03:02+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20230227005632\/en\/774866\/21\/https_commmitre.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/fcw-selects-mitres-dr-jay-schnitzer-as-a-2023-federal-100-honoree\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/fcw-selects-mitres-dr-jay-schnitzer-as-a-2023-federal-100-honoree\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"FCW Selects MITRE\u2019s Dr. Jay Schnitzer as a 2023 Federal 100 Honoree","datePublished":"2023-02-27T17:03:02+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/fcw-selects-mitres-dr-jay-schnitzer-as-a-2023-federal-100-honoree\/"},"wordCount":436,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/fcw-selects-mitres-dr-jay-schnitzer-as-a-2023-federal-100-honoree\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20230227005632\/en\/774866\/21\/https_commmitre.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/fcw-selects-mitres-dr-jay-schnitzer-as-a-2023-federal-100-honoree\/","url":"https:\/\/pharma-trend.com\/en\/fcw-selects-mitres-dr-jay-schnitzer-as-a-2023-federal-100-honoree\/","name":"FCW Selects MITRE\u2019s Dr. Jay Schnitzer as a 2023 Federal 100 Honoree - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/fcw-selects-mitres-dr-jay-schnitzer-as-a-2023-federal-100-honoree\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/fcw-selects-mitres-dr-jay-schnitzer-as-a-2023-federal-100-honoree\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20230227005632\/en\/774866\/21\/https_commmitre.jpg","datePublished":"2023-02-27T17:03:02+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/fcw-selects-mitres-dr-jay-schnitzer-as-a-2023-federal-100-honoree\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/fcw-selects-mitres-dr-jay-schnitzer-as-a-2023-federal-100-honoree\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/fcw-selects-mitres-dr-jay-schnitzer-as-a-2023-federal-100-honoree\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20230227005632\/en\/774866\/21\/https_commmitre.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20230227005632\/en\/774866\/21\/https_commmitre.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/fcw-selects-mitres-dr-jay-schnitzer-as-a-2023-federal-100-honoree\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"FCW Selects MITRE\u2019s Dr. Jay Schnitzer as a 2023 Federal 100 Honoree"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/54276","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=54276"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/54276\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=54276"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=54276"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=54276"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}